PROQR THERAPEUTICS EO-04 Cash Flow Reinvestment Rate

Latest as of December 2023: 0.06x

PROQR THERAPEUTICS EO-04 cash flow reinvestment rate. PROQR THERAPEUTICS EO-04 (0PQ) has a Cash Flow Reinvestment Rate of 0.06x as of December 2023, reinvesting €1.37 Million (capex €1.37 Million ) from operating cash flow of €21.55 Million. Explore 0PQ operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.06x

(Capex + Investments) / Operating CF

Total Reinvested

€1.37 Million

Capex + Investments

Operating Cash Flow

€21.55 Million

EUR

Capital Expenditures

€1.37 Million

EUR

Cash Flow Reinvestment Rate of PROQR THERAPEUTICS EO-04 (2023–2023)

Cash flow reinvestment rate of PROQR THERAPEUTICS EO-04 from 2023 to 2023. Historical reinvestment intensity for PROQR THERAPEUTICS EO-04 across 1 annual periods. Explore how much does PROQR THERAPEUTICS EO-04 reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

PROQR THERAPEUTICS EO-04 Cash Flow Reinvestment Rate by Year (2023–2023)

PROQR THERAPEUTICS EO-04 cash flow reinvestment rate by year from 2023 to 2023. Year-by-year capital reinvestment analysis for PROQR THERAPEUTICS EO-04. For the full cash flow conversion analysis, see how efficiently does PROQR THERAPEUTICS EO-04 generate cash.

Year	Reinvestment Rate	Total Reinvested (EUR)	Operating CF	Capex	YoY Change
2023	0.06x	€1.37 Million	€21.55 Million	€1.37 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow